ANA KRISTIA BERMUDEZ: Open Payments
NPI 1881873750 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 34 payments from 8 companies in 2025. Trend: 2023 $803 · 2024 $694 · 2025 $671
Food & beverage: $637Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $235 |
| AstraZeneca Pharmaceuticals LP | 3 | $149 |
| Amgen Inc. | 4 | $96 |
| Regeneron Healthcare Solutions, Inc. | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| SANOFI PASTEUR INC. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| GENZYME CORPORATION | 1 | $16 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, DUPIXENT, NUCALA, TEZSPIRE, TAKHZYRO, BEYFORTUS, Rhapsido.
Industry payments across CT — which companies pay providers there.
